Purchase Order 36C25624P0791

Award Date 3/21/24
Potential Completion Date 4/30/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $33,300.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract has an ultimate completion date of January 8, 2025. Profounda Inc. has a significant Blanket Purchase Agreement...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $49,950.00, is for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections, to VA medical centers within the Veterans Integrated Service Network 20 (VISN 20). Profounda Inc. holds a...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA), specifically Veterans Integrated Service Network (VISN) 20, to Profounda Inc. for the delivery of Impavido/Miltefosine, a critical medication used to treat leishmaniasis and other drug-resistant infections. The contract, valued at $16,650.00, does not have a set-aside designation and is intended to support the VA's mission of providing healthcare services to veterans by ensuring rapid access to...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a $299,700.00 firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business manufacturer of pharmaceutical products, to provide the medication Impavido (miltefosine) to the Puget Sound VA Medical Center. This sole-source procurement is to acquire this specialized drug for treating Disseminated Cutaneous Acanthamboeba, with a performance period from May 1, 2025, to October 30,...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' (VA) Veterans Health Administration (VHA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer. The $116,550 contract is for the delivery of Miltefosine, a medication used to treat leishmaniasis and other drug-resistant infections in veterans. The contract has an ultimate completion date of September 30, 2024 and is part of a larger $1,127,000 Blanket Purchase Agreement (BPA)...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 23 awarded a $16,750 purchase order to Profounda Inc. for the delivery of 50mg miltefosine capsules. The firm fixed price contract runs from December 14, 2023 through January 13, 2024 and will be performed in Omaha, Nebraska. Profounda Inc. will provide the pharmaceutical products to VA-VHA under this contract to support their healthcare services for veterans. No subcontractors or set aside...
This is a firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Profounda Inc., a self-certified small disadvantaged business and manufacturer of pharmaceutical products. The contract, valued at $99,900.00, is for the delivery of Miltefosine 50mg tablets, a critical medication used to treat leishmaniasis and other drug-resistant infections. This purchase order is part of a larger $1,127,000 Blanket Purchase Agreement (BPA) held by Profounda Inc. with the VA's...
The Department of Veterans Affairs awarded Veterans Medical Distributors, Inc. a firm fixed price purchase order for $43,050 to deliver prosthetic implant items in support of veteran healthcare programs. As a veteran owned small business, Veterans Medical Distributors holds a Federal Supply Schedule contract with the General Services Administration through August 2025, permitting up to $1.5 million in medical product sales to government buyers including wound dressings, bandages, and optic...
The Department of Veterans Affairs (VA) awarded a $2,511,469.95 firm fixed-price delivery order contract to Proaim Americas, LLC, doing business as Proaim Medical, for the express provision of medical supplies, devices, equipment, and software from April 2023 through October 2023. This order was placed under Proaim's existing $420 million indefinite delivery contract with the Defense Logistics Agency Troop Support Medical, which allows the company to provide a wide range of specialized...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Proaim Americas, LLC, a minority-owned limited liability company doing business as Proaim Medical. The $8,994.00 firm-fixed-price delivery order is for 4565834552 - Treatment Pack, 10 units per pack. The contract has an ultimate completion date of July 15, 2025 and was awarded on September 17, 2024. Proaim Medical holds a $420 million Indefinite Delivery Vehicle (IDV) contract...

The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed-price purchase order to Profounda Inc., a self-certified small disadvantaged business and manufacturer, for the delivery of Emergency Patient Profounda Miltefosine Dose Packs. The $16,650 contract has an April 30, 2024 completion date and supports the VHA's mission to provide healthcare services to veterans by ensuring access to this specialty pharmaceutical product. Profounda has previously received numerous federal contracts from the VHA to deliver Impavido/Miltefosine capsules and tablets to VA Medical Centers. This award is not associated with a set-aside program. Profounda also holds a $1,127,000 Blanket Purchase Agreement with the VHA's Veterans Integrated Service Network 8 for Impavido consignment through June 2024 to facilitate rapid treatment of drug-resistant infections.

Generated 4/6/24, 9:44 AM